References
-
1
Calaminus G, Bamberg M, Harms D, Jurgens H, Kortmann R D, Sorensen N, Wiestler O D, Gobel U.
AFP/beta-HCG secreting CNS germ cell tumors: long-term outcome with respect to initial symptoms and primary tumor resection. Results of the cooperative trial MAKEI 89.
Neuropediatrics.
2005;
36
71-77
-
2
Rostasy K M.
Inflammation and neuroaxonal injury in multiple sclerosis and AIDS dementia complex: implications for neuroprotective treatment.
Neuropediatrics.
2005;
36
230-239
-
3
Oehmichen M, Meissner C, Saternus K S.
Fall or shaken: traumatic brain injury in children caused by falls or abuse at home - a review on biomechanics and diagnosis.
Neuropediatrics.
2005;
36
240-245
-
4
Fidzianska A, Kaminska A, Ryniewicz B.
Congenital myopathy with tubular aggregates and tubulofilamentous IBM-type inclusions.
Neuropediatrics.
2005;
36
35-39
-
5
Elleder M, Jerabkova M, Befekadu A, Hrebicek M, Berna L, Ledvinova J, Hulkova H, Rosewich H, Schymik N, Paton B C, Harzer K.
Prosaposin deficiency - a rarely diagnosed, rapidly progressing, neonatal neurovisceral lipid storage disease. Report of a further patient.
Neuropediatrics.
2005;
36
171-180
-
6
Pavone P, Incorpora G, Ruggieri M.
A complex brain malformation syndrome with rhombencephalosynapsis, preaxial hexadactyly plus facial and skull anomalies.
Neuropediatrics.
2005;
36
279-283
-
7
Steinlin M, Pfister I, Pavlovic J, Everts R, Boltshauser E, Capone Mori A, Gubser Mercati D, Hanggeli C A, Keller E, Luetschg J, Marcoz J, Ramelli G P, Roulet Perez E, Schmitt-Mechelke T, Weissert M. the Swiss Societies of Paediatric Neurology and Neonatology .
The first three years of the Swiss Neuropaediatric Stroke Registry (SNPSR): a population-based study of incidence, symptoms and risk factors.
Neuropediatrics.
2005;
36
90-97
-
8
Panetta J, Gibson K, Kirby D M, Thorburn D R, Boneh A.
The importance of liver biopsy in the investigation of possible mitochondrial respiratory chain disease.
Neuropediatrics.
2005;
36
256-259
-
9
Kyllerman M, Rosengren L, Wiklund L M, Holmberg E.
Increased levels of GFAP in the cerebrospinal fluid in three subtypes of genetically confirmed Alexander disease.
Neuropediatrics.
2005;
36
319-323
Reviewers Consulted in 2005
Amthor, H
Angelini, L
Arzimanoglou, A
Ballauff, A
Bertini, E
Bourgeois, B
Brandl, U
Brockmann, K
Camfield, CS
Chiron, C
Conzelmann, E
Crow, J
Dammann, O
Dobyns, WB
Duffner, P
Forssberg, H
Gordon, N
Harzer, K
Heinen, F
Huppi, P
Hornyak, N
Ikonomidou, H
Jackson, L
Jansen, T
Kauschke, C
Kölker, S
Kohlschütter, A
Kramer, H
Kremens, B
Limmroth, V
Lochmüller, H
McLaughlin, JF
Munnich, A
Müller, SP
Neubauer, G
Nowak-Göttel, U
Omran, H
Plecko, B
Rasmussen, M
Rating, D
Reis, J
Rodnitzky, RL
Rostasy, K
Ruggieri, M
Rourke, BP
Schröder, JM
Senderek, J
Shane, AM
Staudt, M
Steinlein, O
Stephani, U
Sukonen, J
Surendran, S
Timmann-Braun, D
Thron, A
Throttenberg, T
Tulinius, M
Turnbull, D
Tuxhorn, J
Ullrich, K
Uyanik, G
Vielringer, A
Vincent, A
Vondris, KA
Walczak, TS
Walters, A
Wirrel, E
Zadik, Z
T. Voit
Department of Pediatrics and Pediatric Neurology · University-Hospital Essen
Hufelandstraße 55
45122 Essen
Germany
eMail: thomas.voit@uni-essen.de
